115 related articles for article (PubMed ID: 38842275)
21. Long non-coding RNA VCAN-AS1 promotes the malignant behaviors of breast cancer by regulating the miR-106a-5p-mediated STAT3/HIF-1α pathway.
Du P; Luo K; Li G; Zhu J; Xiao Q; Li Y; Zhang X
Bioengineered; 2021 Dec; 12(1):5028-5044. PubMed ID: 34365889
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathway.
Gao J; Yu SR; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
J Cell Physiol; 2019 Feb; 234(2):1827-1841. PubMed ID: 30191949
[TBL] [Abstract][Full Text] [Related]
23. DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer.
Liang Y; Zhang CD; Zhang C; Dai DQ
Gastric Cancer; 2020 Mar; 23(2):212-227. PubMed ID: 31463827
[TBL] [Abstract][Full Text] [Related]
24. lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA.
Lv M; Zhong Z; Huang M; Tian Q; Jiang R; Chen J
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1887-1899. PubMed ID: 28779971
[TBL] [Abstract][Full Text] [Related]
25. Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer.
Hirata H; Ueno K; Shahryari V; Tanaka Y; Tabatabai ZL; Hinoda Y; Dahiya R
PLoS One; 2012; 7(11):e51056. PubMed ID: 23226455
[TBL] [Abstract][Full Text] [Related]
26. LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis.
Du C; Wang Y; Zhang Y; Zhang J; Zhang L; Li J
Cell Transplant; 2020; 29():963689720929983. PubMed ID: 32686982
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA NONHSAT101069 promotes epirubicin resistance, migration, and invasion of breast cancer cells through NONHSAT101069/miR-129-5p/Twist1 axis.
Yao N; Fu Y; Chen L; Liu Z; He J; Zhu Y; Xia T; Wang S
Oncogene; 2019 Nov; 38(47):7216-7233. PubMed ID: 31444414
[TBL] [Abstract][Full Text] [Related]
28. Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell resistance to cisplatin by regulating miR-34b-5p/ABCB1 axis.
Luo G; Zhang Y; Wu Z; Zhang L; Liang C; Chen X
Acta Biochim Biophys Sin (Shanghai); 2021 Apr; 53(5):558-566. PubMed ID: 33720323
[TBL] [Abstract][Full Text] [Related]
29. LncRNA RNF144A-AS1 Promotes Bladder Cancer Progression via RNF144A-AS1/miR-455-5p/SOX11 Axis.
Bi H; Shang Z; Jia C; Wu J; Cui B; Wang Q; Ou T
Onco Targets Ther; 2020; 13():11277-11288. PubMed ID: 33177836
[TBL] [Abstract][Full Text] [Related]
30. The ceRNA Mechanism of lncRNA MEG3/miR-21-5p/SPRY2 in Cell Proliferation and Apoptosis in Bladder Cancer.
Hong Y; Li Z; Su Y; Pu H; Zhang X
Crit Rev Eukaryot Gene Expr; 2024; 34(1):55-68. PubMed ID: 37824392
[TBL] [Abstract][Full Text] [Related]
31. MIR-518a-5p Targets ZEB2 to Suppress the Migration and Invasion of Breast-cancer Cells.
Wang L; Guo Z; Zhang S; Zhang X; Sang M; Liu Y; Shan B
Altern Ther Health Med; 2023 Jan; 29(1):137-143. PubMed ID: 35986741
[TBL] [Abstract][Full Text] [Related]
32. MiR-183-5p-PNPT1 Axis Enhances Cisplatin-induced Apoptosis in Bladder Cancer Cells.
Hu QG; Yang Z; Chen JW; Kazobinka G; Tian L; Li WC
Curr Med Sci; 2022 Aug; 42(4):785-796. PubMed ID: 35788944
[TBL] [Abstract][Full Text] [Related]
33. OCT4B mediates hypoxia-induced cancer dissemination.
Lin SC; Chung CH; Chung CH; Kuo MH; Hsieh CH; Chiu YF; Shieh YS; Chou YT; Wu CW
Oncogene; 2019 Feb; 38(7):1093-1105. PubMed ID: 30209362
[TBL] [Abstract][Full Text] [Related]
34. LncRNA GAS5 regulates the Wnt/β-catenin pathway through the miR-18a-5p/AXIN2/GSK3β axis to inhibit the proliferation and migration of bladder cancer cells.
Zhang Z; Liu T; Cheng C; Wang J; Wang C; Huang H; Li Y
Carcinogenesis; 2022 Dec; 43(12):1176-1189. PubMed ID: 36331809
[TBL] [Abstract][Full Text] [Related]
35. Knockdown of lncRNA ZNRD1-AS1 inhibits progression of bladder cancer by regulating miR-194 and ZEB1.
Gao Z; Li S; Zhou X; Li H; He S
Cancer Med; 2020 Oct; 9(20):7695-7705. PubMed ID: 32862492
[TBL] [Abstract][Full Text] [Related]
36. The LINC01929/miR-6875-5p/ADAMTS12 Axis in the ceRNA Network Regulates the Development of Advanced Bladder Cancer.
Xiong Y; Pang M; Du Y; Yu X; Yuan J; Liu W; Wang L; Liu X
Front Oncol; 2022; 12():856560. PubMed ID: 35646642
[TBL] [Abstract][Full Text] [Related]
37. CircMMP11 regulates proliferation, migration, invasion, and apoptosis of breast cancer cells through miR-625-5p/ZEB2 axis.
Qi L; Sun B; Yang B; Lu S
Cancer Cell Int; 2021 Feb; 21(1):133. PubMed ID: 33632213
[TBL] [Abstract][Full Text] [Related]
38. Sevoflurane Suppresses the Migration, Invasion, and Epithelial-Mesenchymal Transition of Breast Cancer Cells Through the miR-139-5p/ARF6 Axis.
Wu T; Sun L; Wang C; Yu P; Cheng L; Chen Y
J Surg Res; 2021 Feb; 258():314-323. PubMed ID: 33317757
[TBL] [Abstract][Full Text] [Related]
39. LncRNA TDRKH-AS1 promotes breast cancer progression via the miR-134-5p/CREB1 axis.
Ding Y; Huang Y; Zhang F; Gong L; Liang C; Ding K; He X; Ding X; Chen Y
J Transl Med; 2023 Nov; 21(1):854. PubMed ID: 38008726
[TBL] [Abstract][Full Text] [Related]
40. Long Noncoding RNA
Liu B; Luo C; Lin H; Ji X; Zhang E; Li X
Cancer Biother Radiopharm; 2021 Aug; 36(6):456-466. PubMed ID: 32749857
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
